Skip to content

Clinical trials

Schizophrenia, Treatment-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia, Treatment-Resistant Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20101
20111
20122
20131
20151
20162
20174
20196
20201
20212
20224
20238
20243
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status11
Recruiting11
Terminated4
Not yet recruiting3
Active, not recruiting2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
All India Institute of Medical Sciences, Bhubaneswar3
Centre for Addiction and Mental Health3
Ciusss de L'Est de l'Île de Montréal3
Shanghai Mental Health Center3
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2
University of Sao Paulo2
Azur Pharma, Inc1
Boston VA Research Institute, Inc.1
Bradley Lega1
Central Institute of Mental Health, Mannheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia, Treatment-Resistant49
Schizophrenia27
Psychotic Disorders8
Hallucinations7
Obesity2
Sialorrhea2
Sleep Initiation and Maintenance Disorders2
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1

Trials

Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.